You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
桂林三金(002275.SZ):寶船生物取得BC008抗體注射液臨牀試驗批准通知書的文本信息
格隆匯 05-17 15:59

格隆匯5月17日丨桂林三金(002275.SZ)公吿稱,公司於2022年4月2日發佈了《關於控股孫公司獲得藥物臨牀試驗默示許可的公吿》,公司控股孫公司寶船生物醫藥科技(上海)有限公司(簡稱“寶船生物”)獲得了國家藥品監督管理局核准簽發的BC008抗體注射液的臨牀試驗批准通知書,但因上海市疫情管控原因,寶船生物暫時無法拿到該臨牀試驗批准通知書的文本信息。近日,公司接到寶船生物通知,其已取得上述臨牀試驗批准通知書的文本信息。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account